Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway.

[1]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[2]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[3]  H. Erdjument-Bromage,et al.  The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent Mechanism , 1997, Cell.

[4]  G. Ghosh,et al.  Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA , 1998, Nature.

[5]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[6]  H. Sakurai,et al.  IκB Kinases Phosphorylate NF-κB p65 Subunit on Serine 536 in the Transactivation Domain* , 1999, The Journal of Biological Chemistry.

[7]  M. Karin.  How NF-κB is activated: the role of the IκB kinase (IKK) complex , 1999, Oncogene.

[8]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[9]  S. Westerheide,et al.  Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II* , 2000, The Journal of Biological Chemistry.

[10]  C. Pickart,et al.  Mechanisms underlying ubiquitination. , 2001, Annual review of biochemistry.

[11]  B. Wadzinski,et al.  Protein Phosphatase 2A Interacts with and Directly Dephosphorylates RelA* , 2001, The Journal of Biological Chemistry.

[12]  C. Allis,et al.  Translating the Histone Code , 2001, Science.

[13]  Eric Verdin,et al.  Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation , 2001, Science.

[14]  W. Greene,et al.  Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB , 2002, The EMBO journal.

[15]  C. Wijmenga,et al.  The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes , 2003, Nature.

[16]  C. Allis,et al.  Histone and chromatin cross-talk. , 2003, Current opinion in cell biology.

[17]  G. Haegeman,et al.  Transcriptional activation of the NF‐κB p65 subunit by mitogen‐ and stress‐activated protein kinase‐1 (MSK1) , 2003, The EMBO journal.

[18]  A. Durán,et al.  Essential role of RelA Ser311 phosphorylation by ζPKC in NF‐κB transcriptional activation , 2003 .

[19]  A. Ryo,et al.  Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. , 2003, Molecular cell.

[20]  C. Sardet,et al.  Post-activation Turn-off of NF-κB-dependent Transcription Is Regulated by Acetylation of p65* , 2003, The Journal of Biological Chemistry.

[21]  Klaus Resch,et al.  Phosphorylation of Serine 468 by GSK-3β Negatively Regulates Basal p65 NF-κB Activity* , 2004, Journal of Biological Chemistry.

[22]  S. Saccani,et al.  Degradation of Promoter-bound p65/RelA Is Essential for the Prompt Termination of the Nuclear Factor κB Response , 2004, The Journal of experimental medicine.

[23]  W. Greene,et al.  p53 Induces NF-κB Activation by an IκB Kinase-independent Mechanism Involving Phosphorylation of p65 by Ribosomal S6 Kinase 1* , 2004, Journal of Biological Chemistry.

[24]  M. Schmitz,et al.  Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to , 2004, The Journal of biological chemistry.

[25]  M. Mayo,et al.  Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase , 2004, The EMBO journal.

[26]  K. Yeh,et al.  Suppression of MEK/ERK Signaling Pathway Enhances Cisplatin-induced NF-κB Activation by Protein Phosphatase 4-mediated NF-κB p65 Thr Dephosphorylation* , 2004, Journal of Biological Chemistry.

[27]  P. Dent,et al.  Kinase 1 Activation Downregulation, and C-jun N-terminal Mediated by Oxidative Damage, Xiap Leukemia Cells through a Process B Activation Potentiates Apoptosis in Κ Nf- Inhibitor-induced Rela/p65 Acetylation and Blockade of Histone Deacetylase , 2005 .

[28]  Leonard Buckbinder,et al.  NF-κB RelA Phosphorylation Regulates RelA Acetylation , 2005, Molecular and Cellular Biology.

[29]  John C. Wilkinson,et al.  COMMD Proteins, a Novel Family of Structural and Functional Homologs of MURR1* , 2005, Journal of Biological Chemistry.

[30]  Mark T Bedford,et al.  Arginine methyltransferase CARM1 is a promoter‐specific regulator of NF‐κB‐dependent gene expression , 2005, The EMBO journal.

[31]  C. Iadecola,et al.  cis-Acting Element-specific Transcriptional Activity of Differentially Phosphorylated Nuclear Factor-κB* , 2005, Journal of Biological Chemistry.

[32]  Toby Lawrence,et al.  IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation , 2005, Nature.

[33]  R. Schwabe,et al.  IKKβ phosphorylates p65 at S468 in transactivaton domain 2 , 2005 .

[34]  Xiang-Jiao Yang,et al.  Multisite protein modification and intramolecular signaling , 2005, Oncogene.

[35]  N. Perkins,et al.  Regulation of NF‐κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor , 2005, The EMBO journal.

[36]  D. Longo,et al.  Phosphorylation of RelA/p65 on Serine 536 Defines an IκBα-independent NF-κB Pathway* , 2005, Journal of Biological Chemistry.

[37]  M. Schmitz,et al.  Inducible Phosphorylation of NF-κB p65 at Serine 468 by T Cell Costimulation Is Mediated by IKKϵ* , 2006, Journal of Biological Chemistry.

[38]  Philip Smith,et al.  Breast Cancer Metastasis Suppressor 1 Functions as a Corepressor by Enhancing Histone Deacetylase 1-Mediated Deacetylation of RelA/p65 and Promoting Apoptosis , 2006, Molecular and Cellular Biology.

[39]  H. Erdjument-Bromage,et al.  Histone demethylation by a family of JmjC domain-containing proteins , 2006, Nature.

[40]  Tomoaki Koga,et al.  Synergistic Activation of NF-κB by Nontypeable H. influenzae and S. pneumoniae Is Mediated by CK2, IKKβ-IκBα and p38 MAPK , 2006 .

[41]  E. Nabel,et al.  Protein Methyltransferase 2 Inhibits NF-κB Function and Promotes Apoptosis , 2006, Molecular and Cellular Biology.

[42]  N. Perkins,et al.  Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation. , 2006, Cancer research.

[43]  N. Perkins.  Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway , 2006, Oncogene.

[44]  Michael A Berman,et al.  RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. , 2006, Molecular cell.

[45]  J. Basu,et al.  TLR4-Dependent NF-κB Activation and Mitogen- and Stress-Activated Protein Kinase 1-Triggered Phosphorylation Events Are Central to Helicobacter pylori Peptidyl Prolyl cis-, trans-Isomerase (HP0175)-Mediated Induction of IL-6 Release from Macrophages1 , 2006, The Journal of Immunology.

[46]  A. Baldwin,et al.  Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression , 2006, Oncogene.

[47]  M. Mayo,et al.  IκB Kinase α-Mediated Derepression of SMRT Potentiates Acetylation of RelA/p65 by p300 , 2006, Molecular and Cellular Biology.

[48]  Mazhar Adli,et al.  IKK-i/IKKϵ Controls Constitutive, Cancer Cell-associated NF-κB Activity via Regulation of Ser-536 p65/RelA Phosphorylation* , 2006, Journal of Biological Chemistry.

[49]  Lin-Feng Chen,et al.  TGF‐β induces p65 acetylation to enhance bacteria‐induced NF‐κB activation , 2007 .

[50]  K. Ito,et al.  Impact of post-translational modifications of proteins on the inflammatory process. , 2007, Biochemical Society transactions.

[51]  D. Cilloni,et al.  CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536 , 2007, Leukemia.

[52]  M. Naumann,et al.  Beyond IκBs: alternative regulation of NF‐KB activity , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  W. Yarbrough,et al.  LZAP, a Putative Tumor Suppressor, Selectively Inhibits NF-κB , 2007 .

[54]  X. Mao,et al.  COMMD1 promotes the ubiquitination of NF‐κB subunits through a cullin‐containing ubiquitin ligase , 2007, The EMBO journal.

[55]  M. Jamaluddin,et al.  TNF-α-induced NF-κB/RelA Ser276 phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway , 2007 .

[56]  Y. Kooyk,et al.  C-Type Lectin DC-SIGN Modulates Toll-like Receptor Signaling via Raf-1 Kinase-Dependent Acetylation of Transcription Factor NF-κB , 2007 .

[57]  A. Jetten,et al.  NF-κB-dependent Transcriptional Activation in Lung Carcinoma Cells by Farnesol Involves p65/RelA(Ser276) Phosphorylation via the MEK-MSK1 Signaling Pathway* , 2008, Journal of Biological Chemistry.

[58]  E. Seto,et al.  Lysine acetylation: codified crosstalk with other posttranslational modifications. , 2008, Molecular cell.

[59]  Jerry L. Workman,et al.  Crosstalk among Histone Modifications , 2008, Cell.

[60]  Yang Shi,et al.  Mechanisms involved in the regulation of histone lysine demethylases. , 2008, Current opinion in cell biology.

[61]  H. Rehrauer,et al.  Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65 , 2008, Nucleic acids research.

[62]  B. Aggarwal,et al.  Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalp , 2008, Blood.

[63]  Ming-Ming Zhou,et al.  Brd4 Coactivates Transcriptional Activation of NF-κB via Specific Binding to Acetylated RelA , 2008, Molecular and Cellular Biology.

[64]  S. Choudhary,et al.  RelA Ser276 Phosphorylation Is Required for Activation of a Subset of NF-κB-Dependent Genes by Recruiting Cyclin-Dependent Kinase 9/Cyclin T1 Complexes , 2008, Molecular and Cellular Biology.

[65]  K. Helin,et al.  Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. , 2008, Genes & development.

[66]  S. Ghosh,et al.  Repression of gene expression by unphosphorylated NF-kappaB p65 through epigenetic mechanisms. , 2008, Genes & development.

[67]  J. Anrather,et al.  Termination of NF-κB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase , 2009, The EMBO journal.

[68]  J. Briones,et al.  Bcl‐10 protein highly correlates with the expression of phosphorylated p65 NF‐κB in peripheral T‐cell lymphomas and is associated with clinical outcome , 2009, Histopathology.

[69]  R. Garofalo,et al.  Respiratory Syncytial Virus Infection Induces a Reactive Oxygen Species-MSK1-Phospho-Ser-276 RelA Pathway Required for Cytokine Expression , 2009, Journal of Virology.

[70]  Kyung-Chul Choi,et al.  Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. , 2009, Cancer research.

[71]  Lin-Feng Chen,et al.  Helicobacter pylori CagA activates NF‐κB by targeting TAK1 for TRAF6‐mediated Lys 63 ubiquitination , 2009, EMBO reports.

[72]  Shuang Huang,et al.  Synergistic Induction of Inflammation by Bacterial Products Lipopolysaccharide and fMLP: An Important Microbial Pathogenic Mechanism1 , 2009, The Journal of Immunology.

[73]  M. Schmitz,et al.  Phosphorylation of NF‐κB p65 at Ser468 controls its COMMD1‐dependent ubiquitination and target gene‐specific proteasomal elimination , 2009, EMBO reports.

[74]  C. Van Waes,et al.  Nuclear NF-κB p65 Phosphorylation at Serine 276 by Protein Kinase A Contributes to the Malignant Phenotype of Head and Neck Cancer , 2009, Clinical Cancer Research.

[75]  Hua Yu,et al.  Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. , 2009, Cancer cell.

[76]  Lin-Feng Chen,et al.  Synergistic induction of nuclear factor-kappaB by transforming growth factor-beta and tumour necrosis factor-alpha is mediated by protein kinase A-dependent RelA acetylation. , 2009, The Biochemical journal.

[77]  Aparna Repaka,et al.  GCN5 is a required cofactor for a ubiquitin ligase that targets NF-kappaB/RelA. , 2009, Genes & development.

[78]  N. Kelleher,et al.  Negative regulation of NF‐κB action by Set9‐mediated lysine methylation of the RelA subunit , 2009, The EMBO journal.

[79]  S. Shreeram,et al.  WIP1 phosphatase is a negative regulator of NF-κB signalling , 2009, Nature Cell Biology.

[80]  H. Inoue,et al.  Licochalcone A significantly suppresses LPS signaling pathway through the inhibition of NF-kappaB p65 phosphorylation at serine 276. , 2009, Cellular signalling.

[81]  E. Tajkhorshid,et al.  Functional Interplay between Acetylation and Methylation of the RelA Subunit of NF-κB , 2010, Molecular and Cellular Biology.

[82]  L. Stark,et al.  Nucleolar targeting of RelA(p65) is regulated by COMMD1-dependent ubiquitination. , 2010, Cancer research.